What Is CBD? A Quick Primer
Cannabidiol (CBD) is a non-intoxicating compound from cannabis and hemp. It does not cause a “high.” Unlike over-the-counter oils and gummies, the FDA-approved prescription form is highly purified and standardized.
For certain hard-to-treat epilepsies, CBD has moved from curiosity to clinic, backed by randomized controlled trials and regulatory review.
Clinical Research on cbd for epilepsy: What the Trials Show
Large, placebo-controlled studies have tested prescription CBD as an add-on to standard anti-seizure medications. The results are consistent: meaningful reductions in specific seizure types for some patients.
FDA-Approved Indications
- Lennox–Gastaut syndrome (LGS), age 2 and older
- Dravet syndrome, age 2 and older
- Tuberous sclerosis complex (TSC), age 1 and older
Key Medical Findings from Major Trials
- Dravet syndrome: Median reduction in convulsive seizures around 39% with CBD vs ~13% with placebo.
- LGS: Median reduction in drop seizures about 37–44% with CBD vs ~17–22% with placebo.
- TSC: Overall seizure reductions around 48–49% with CBD vs ~24% with placebo.
Not everyone responds, and “seizure-free” outcomes are uncommon. Still, the odds of a clinically meaningful reduction improved for a subset, especially alongside careful monitoring.
How CBD May Work in the Brain
CBD interacts with multiple pathways involved in neuronal excitability and inflammation. It does not act like THC and does not directly stimulate classic cannabinoid receptors the same way.
- Modulates GPR55 and TRPV1 channels that influence neuronal firing
- Impacts adenosine signaling, which can be neuroprotective
- May alter glutamate and GABA balance, relevant to seizure thresholds
Think of CBD as a “multi-target” compound that stabilizes networks rather than a single-receptor switch.
Safety, Side Effects, and Interactions: cbd for epilepsy in Real Life
Safety data from trials and post-approval use are robust. Most side effects are dose-related and manageable with monitoring.
Common Side Effects
- Sleepiness or fatigue
- Decreased appetite and weight loss
- Diarrhea or GI discomfort
- Elevated liver enzymes (especially with valproate)
Important Drug Interactions
- Clobazam: CBD can increase the active metabolite (N-desmethylclobazam), boosting sedation. Dose adjustments are common.
- Valproate: Higher risk of liver enzyme elevations; requires regular liver function tests (LFTs).
- Warfarin and some anticoagulants: Possible INR changes; close monitoring is essential.
Experience: A Real-World Story
Maya, a 9-year-old with Dravet syndrome, had frequent convulsive seizures despite multiple medications. With her neurologist, her family added prescription CBD. Over eight weeks, her convulsive seizures fell by about 40% from baseline. She felt sleepier at first, and her clobazam dose was reduced to curb sedation. Liver enzymes stayed normal with monthly checks.
Maya’s story mirrors trial outcomes—meaningful improvement, ongoing meds, and careful follow-up. Results vary, but structured monitoring helped her family and care team adjust safely.
Step-by-Step: How to Discuss CBD with Your Neurologist
- Clarify your goal: fewer seizures, better recovery time, or improved daily functioning.
- Share your history: seizure type(s), current meds, prior trials, lab results, and rescue plan.
- Ask about fit: Do your seizures resemble those in the CBD studies (LGS, Dravet, TSC)?
- Review interactions: Especially clobazam, valproate, and any anticoagulants.
- Plan monitoring: Baseline LFTs, follow-ups at 1, 3, and 6 months, then as needed.
- Discuss source: Prescription CBD is preferred for epilepsy. OTC products are not substitutes for the approved medication.
What About Dosing?
Prescription CBD is typically started low and increased gradually. Many clinicians begin at 5 mg/kg/day divided twice daily, then titrate to 10–20 mg/kg/day based on response and tolerability. For TSC, higher maintenance doses (up to 25 mg/kg/day) may be considered per the FDA label.
Your neurologist will tailor dosing and adjust other meds to manage side effects and interactions.
OTC Products vs Prescription: Quality Matters
Over-the-counter CBD oils and gummies vary widely in purity and dose. They are not FDA-approved for treating seizures and should not replace prescribed therapies.
Quality Checklist if You Consider OTC CBD for General Wellness
- Third-party Certificate of Analysis (COA) for each batch
- Lab accredited to ISO/IEC 17025
- Clear CBD amount per milliliter or per capsule
- No detectable heavy metals, pesticides, or solvent residues
For seizure support, speak with your neurologist before trying any product. Prescription options remain the standard when treating epilepsy.
Who Might Consider CBD?
- Patients with LGS, Dravet syndrome, or TSC who still have seizures despite standard care
- Families open to regular lab monitoring and adjustments to other medications
- Adults and children needing an add-on therapy with a different mechanism
If you are outside these groups, your neurologist can help weigh potential benefits vs risks based on seizure type and overall neurological wellness.
Maximizing Benefit: Practical Tips
- Keep a seizure diary with triggers, duration, and recovery time.
- Use consistent dosing times and avoid missed doses.
- Limit alcohol and discuss all supplements with your doctor.
- Manage sleep, stress, and hydration—small habits can support outcomes.
These habits won’t replace treatment, but they can complement a broader plan.
Frequently Asked Questions
Is CBD actually approved to treat epilepsy?
Yes. The FDA approved a purified, prescription form of CBD for LGS and Dravet (age 2+) and for TSC (age 1+). Over-the-counter CBD products are not approved for seizure treatment.
How long until I know if CBD is helping?
Many patients and clinicians reassess at 4–8 weeks after reaching a stable dose. Some notice changes sooner, but consistent tracking and dose adjustments are important.
Can CBD replace my current anti-seizure meds?
Do not stop or replace medications on your own. In trials, CBD was typically added to existing regimens. Any changes should be guided by your neurologist.
What are the biggest safety concerns?
Sleepiness, GI issues, appetite changes, and potential liver enzyme elevations. Interactions with clobazam and valproate are well-known, so monitoring is key.
Does CBD make you high?
No. CBD is non-intoxicating. Prescription CBD contains negligible THC and does not produce a high.
Conclusion
For certain severe epilepsies, prescription CBD offers evidence-based potential to reduce seizures when standard treatments aren’t enough. It’s not a cure, and it requires careful monitoring, but for the right patients it can be a meaningful tool—supported by strong clinical data and real-world experience.